A series of reform measures have recently been introduced or will be taken by the CSRC. The commission plans to raise the quota for the RMB Qualified Foreign Institutional Investor (RQFII) scheme by 200 billion yuan, expand the scope of qualified foreign institutional investors, and loosen restrictions on the investment ratio.
It will also accelerate the innovative development of securities companies, launch a differentiated personal income tax scheme according to dividend payments, and introduce new regulations on equity incentives for employees of listed companies. These measures are expected to play a positive role in improving the structure of investors, increasing market liquidity, and guiding market investment.
Chairman of the Chinese Securities Regulatory Commission Guo Shuqing pointed out that the development of capital market is beneficial to increase of the source of wealth and residents' property income and enhance social mobility. China's capital market is bound to usher in a new stage of sustained, steady and rapid development, make a significant contribution to the successful restructuring of China's economy and society and bring more favorable and lucrative investment returns to investors.
The focus of China's medical insurance system reform in the future is put on how to introduce the market competition mechanism, include the insurance industry into health care reform and solve the problems of expensive medical bills and difficult access to quality medical services.
Under a well-established medical insurance system, common people can not only afford the medical expense but also easily access to quality medical services and settle accounts. Therefore, the insurance industry especially commercial insurance agencies will play an irreplaceable role.
China has become the world's most important emerging country of insurance industry, with an average increase of premium income reaching nearly 19 percent in the past 10 years.
Pretty model shines at Guangzhou Auto Show Hyundai Motor stage